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Some fully fused quinazoline derivatives have been synthesized via condensation of 3-
formylpyrazolo[5,1-b]quinazolin-9(lH)one 2 with bifunctional reagents followed by ring closure reactions.
The structures of the products have been established by their elemental analyses and spectral data (UV, IR,
IH NMR, mass and X-ray). The antibacterial activity of some products have been also described.
Compounds 7, 12b and 13 show a relatively better activity against some tested bacteria in comparison with
gentamycin.
4-Quinazolinone derivatives play a vital role in
many biological processes and as synthetic drugs'".
Furthermore, many fused quinazolinones are found
to exhibited remarkable pharmacological agents'".
In search for new antimicrobial agents, it was
thought worthwhile to incorporate some additional
heterocyclic moieties in the quinazoline nucleus and
study their biological activity via the interaction
between formylpyrazoloquinazolinone 2 with nitro-
gen and oxygen compounds. The starting compound
3-formylpyrazolo[5, l-b ]quina-zolin-9(1H)one 28
was obtained from formylation of 3-amino-2-
methylquinazolin-4-one 1 by treatment with DMF-
POCl3 [Vilsmeier-Haak reagent].
Condensation of 2 with hydroxylamine
hydrochloride, hydrazine hydrate, semicarbazide
hydrochloride, thiosemicarbazide, 4-aminophenol
and 4-aminom::etophenone refluxing in ethanol,
produced 3a-f (Scheme I). Structure of 3 was
established from elemental analyses and spectral
data (Table I). IR spectrum of 3e showed bands due
to NH-OH, C=O and exo, endo CH=N functional
groups. Its UV spectrum revealed the presence of
absorption band at ",",ax 305, 349 and 485 nm in the
visible region. These bands reported the 1t* electron
transition and the charge transfer band respectively.
The greater reactivity of the hydrogen atom of the
NH of quinazolinone 2 is presumably due to its
favourable location between two carbonyl functions
in position 9 and CHO group in the position 3 of
pyrazoloquinazolinone. Thus, cyclization of 3a by
refluxing in abs. ethanol-fused sodium acetate"
yielded quinazolino[l ,2-b:2,3-b ]dipyrazolo-l O-one
4, while attempts to the cyclization of 3b using gl.
acetic acid-fused sodium acetate afforded 6-methyl-
I ,2,4-triazino[5,6:4,5]pyrazolo[5, I :2,3']quinazololin-
12- one 5.
The structures 4 and 5 were preferred on the
following' grounds: i) absence of NH or OH
absorption bands in the IR spectra, ii) the presence
of only one c=o absorption band at 1677 cm-I .
On the other. hand addition of HCN to
thiosemicarbazone 3d in the presence of gl. acetic
acid-ethanol" afforded 4H-3( o-cyano-c-thiosemi-
carbazido )methylpyrazolo[5, l-b ]quinazolin-9-one 6,
which on boiling with cone, HCl furnished" 6-
[(4H)pyrazolo[5, 1-b]quinazolin-9-one-3-yl]-I, 6-di-
hydro-3-mercapto-1 ,2,4-triazin-5( 4H)one 7, while
basic cyclization of 7 by refluxing with aq. KOIt
produced 3H-5-mercapto-1,2,4-triazino[5',6' : 2,3]-
[4,5-c :1,5-a]pyrazolo-quinazolin-12-one 8 (Scheme
I).
Structure of compounds 6-8 was confirmed from
their elemental analyses and spectral data (Table I).
Their IR spectra showed characteristic bands at
2700 (SH) and 1200-1100 cm' (C-S) with
disappearance of band at 2300-2200 cm-! (CN) in 7
and 8 while IR spectra of 6 and 8 revealed only one
absorption band at 1693 cm-! due to cyclic C=O of
quinazolinone and a broad band at 3300-3100 cm'
was observed in case of 7 and 8 due to cyclic
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hydrazo structure. In addition, structure assigned to
8 was verified from IH NMR spectrum which
showed signals at 5 2.8 (s, IH, of pyrole moiety),
7.5-8.5 (m, 5H, benzo protons of quinazoline and
CH ofpyrazole moiety), 10.1 (s, IH, SH), 10.4 and
11.0ppm (each singlet for NH of 1,2,4-triazine).
Conversion of 6 to 8 was. established via acidic
hydrolysis of cyano group to carboxylic group
followed by cyclization and then elimination of a
molecule of water by refluxing with aq. KOH.
Condensation of 1 with 2 gave the Schiff base 9
which on refluxing with sodium methoxide afforded
the adduct 10. Reaction of arylidine 9 with
mercaptoacetic acid in dry dioxane-fused sodium
sulphate yielded the thiazolidin-4-one 11 (Scheme
I).
Structures of 10 and 11 were deduced from
elemental analyses and IR spectral data. Compound











region due to c=o and C-O-R, while that of 11
exhibited absorption bands at 3120 (NH of
quinazoline), 2880 (aliphatic CH), 1740, 1700, 1680
(3 C=O of quinazoline and thiazolidine-d-onej'".
On the other hand, condensation of 3-
formylpyrazolo[5,I-b]quinazolin-9-(IH) one 2 with
acetophenone derivatives in gl. acetic acid, afforded
the chalcones 12 a,b. Cycloaddition reaction of 12
a,b by boiling with ethanol in the presence of a few
drops of piperidine'< gave heterotricyclic moiety 13.
The chemical transformation of 12 to 13 is outlined
in Chart 1.
Structures of 12 a,b were deduced from their
elemental analyses and spectral data. Their IR
spectra showed absorption bands at 3190 (NH of
quinazoline), 3067 (aromatic CH), 2926 (aliphatic
CH), 1690 (C=O), 1601 (C=C), 1573 cm-I (C=N);
'H NMR spectrum of 12b revealed the presence of
signals at 6.8-7.1 (m, 2H, -CH-CH-), 7.4-8.5 (m,
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8H, pyrazolo & aromatic protons) and 8.8 (s, tH,
NH). UV spectrum of 12b in DMF displayed Amax at
526 nm with fluorescence in UV light, as possible




Refluxing compound 12b in ethanol with a few
drops of piperidine afforded compound 13. Its
structure was established on the basis of elemental
analyses and spectral data. IR spectrum of it showed
absorption bands at 1694, 1660 (2 C=O), 2900, 1490
(str. and def. CH2) and 1530, 1320 em" (asy. and
sy. N02) with absence of a band due to OH or NH
groups. Finally the structure of 13 was confitmed
from mass spectra which showed a molecular ion
peak at rnIz 360 (1.23%), a base peak at rnIz 150
(100%) attributed to p-nitrobenzoyl ion and under
further fragmentation arrived to benzyene radical at
rnIz 76 (28.6%). All fragmentation paths leading to
various daughter ions deduced the postulated
structure (Chart II). In addition, compound 13 did
not give phenolic test with FeCl3 solution.
a.,~Unsaturated ketones 12 a,b reacted with
hydroxylamine hydrochloride in the presence of
pyridine via Michael addition reaction to give
isoxazole derivatives 14 a,b. Structures of these
products were elucidated by spectroscopic analyses.
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Chart 2
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Table I---Physical and spectral data of the compounds 3-14
IR(cm-l)
OH NH SH CO C=N C-S C-O-R
3500 3090 1670 1600
3200 1675 1610
3300 3100 1680 1620
3200 2700 1670 1590 1190
Compd. Solvent M.P. Yield Mol. formula"
eC) % (M. wt.)
3a EtOH 155 80 CIIHsN.02
(228)
3b EtOH 295 75 CIIH9NsO
(227)
3c EtOH 300 100 CI2HION602
(270)
3d EtOH 280 76 C12HION6OS
(286)
3e EtOH 280 90 C17H\3N402
(305)
3f EtOH 238 88 CI~ISN.02
(331)
4 EtOH 270 75 CIIH6N.O
(210)
S EtOH 295 70 CI3H~sO
(251)
6 Oil. 290 84 C\3HIIN,oS
DMF (313)
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*All the compounds gave satisfactory ofC, H, and N analyses. Sulfer element has been determined by X-ray analyses:
3d: EOund 10.62; Calcd 11.18%; 6: Found 9.61; Calcd 10.22%; 7: Found 9.78; Calcd 10.19%; 8: Found 9.99; Calcd
10.81%; 11: Found 6.80; Calcd 7.20%.
W (DMF, A....x nm): 3e: 305,349,485; 12b: 526; 14b: 339,526.
·H NMR'(OMSO) 0:8: 2.8 (IH ofpyro1es), 3.1 (H ofpyrazo1e), 7.5-8.5 (l4H benzo ofquinazoline), \0.1 (IH, SH),
10.4 and I \.0 (each IH, NH of 1,2,4-triazine); 12b: \.5 (3H, CH3), 3.5 (lH, pyrazole), 7.5-7.7 (2H, CH=CH), 7.8-8.1












which are correlated to the NH. CH2, C=O and C-O-
N stretching frequencies of these compounds. The
electronic spectra of these led further support to the
proposed structure where they lack the absorption
bands due to extended conjugation.
Antimicrobial activities. Compounds 3-13 have
been tested for their antimicrobial evaluation against
S. aures, S. marcescens, B. subtilis, C, albine, E. coli
and M lutea by the disc method" using DMF as
solvent and gentamycin was used as standard at
three different concentration (100, 500, and 1000
ug/ml) and growth inhibition was calculated.
The results showed that compounds 8 and 13
were active against E. coli, while compounds 6, 7
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Table II---Antimicrobial activities of the compounds 3-13
Compd* S. aures S. marcescencs B. subtilis C. albine E. coli M. lutea
3a
3b
3c 10 II 9 9 8 8
3d 12 14 10 8 10 7




6 14 15 17 12 10 12
7 16 13 15 II II 12




12b 16 14 14 11 8 6
13 17 16 15 12 21 10
14
Gentamycin 23 23 24 23 23 20
*Diameter of inhibition zones
and 8 were active against S. aures, S. lutes and B.
subtilis. All other compounds, exhibited varying
degree (20-30%) of the antimicrobial activity.
Compound 8 which was substituted with thioxo-
1,2,4-triazine moiety to the pyrazoloquinazolinone
showed maximum activity (38%). When phenyl ring
was substituted with nitro group (at position-4),
compound 13 showed maximum activity (34%),
while both compounds 6 and 7 containing
thiosemicarbazide and/or 3-mercapto-5-hydroxy-
1,2,4-triazine moiety exhibited greater degree of
inhibition when compared with other tested
compounds (Table II). In conclusion, the
compounds which contain the mercapto-l,2,4-
triazine moiety, enhanced the inhibition percentage
of the tested organisms.
Experimental Section
Melting points are uncorrected. IR spectra (KBr)
were recorded on a Perkin-Elmer 293 FT
spectrophotometer ('-malt in cm"), UV spectra (in
DMF) on a LASTACQU. MRD (300-400) test
spectrophotomer ('-malt in nrn), IH NMR spectra on a
EM NMR spectrometer 200 MHz PMR using
DMSO and/or acetone as a solvent and TMS as
internal reference (chemical shifts in 8, ppm) and
mass spectra on GCMS qp 1000 ex Schemimadzu
instrument (70 eV). X-ray. measurement were
recorded in X-ray phosphorescences. Elemental
analysis were performed on a Perkin-Elmer CHN
240A analyzer in unite, Cairo University (ARE).
Synthesis of condensation derivatives 3 a-f:
General method. A suspension of 2 (10 m. molt in
ethanol (50 mL) and the appropriate amino
compounds namely hydroxylamine hydrochloride
(in H20), hydrazine hydrate, semicarbazide (in
H20), thiosemicarbazide (in hot water, drops of
acetic acid), p-aminophenol and p-amino-
acetophenone (each 10 m. mol) was refluxed for lh,
cooled and poured onto ice. The solid thus obtained
was crystallized from the suitable solvent to give
3 a-f (Table I).
Synthesis of quinazolino[1,2-b : 3,2-b]dipyra-
zoio-IO-one 4. A suspention of3a (10 mrnol) in abs.
ethanol (50 mL) and fused sodium acetate (5g) was
heated under reflux for 4h, cooled and poured onto
ice. The resultant solid was crystallized to give 4
(Table I).
Cyclization of 3b into heterotricyclic com-
pound 5. A solution of 3b (l0 mrnol) in gl acetic
acid (100 mL) and fused sodium acetate (5 g) was
refluxed for 2 h, cooled and poured onto ice. The
solid obtained was filtered off and recrystallized to
give 5 (Table I).
Synthesis of 4H-3-(a-cyano-a-thiosemicarba-
zido)methyl-pyrazolo[5,1-b)quinazolin-9-one 6.
To 3d (5 mmol) in ethyl alcohol (50 mL) and gl
acetic acid (50 ml.), aq solution of sodium cyanide
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(5 mmol in H20 5 mL) was added. The reaction
mixture was refluxed for 6 h, cooled and poured
onto ice. The solid obtained was filtered off and
recrystallized to give 6 (Table I).
Acidic hydrolysis of 6:Synthesis of 6-(4H-
pyrazolo(5, I-bJquinazolin-9-one-3-yl)-I, 6-dihy-
dro-3-mercapto-1,2,4-triazin-5(4H)one 7. To 6 (5
mmol),HCl (20%, 20 mL) was added and the
reaction mixture was refluxed for 10 h. The solid
product was filtered off and recrystallized to give 7
(Table I).
Basic cyclization of 7:Synthesis of 3H-S-
mercapto-l, 2, 4-triazino(5,6 : 2,3)[4, 5- c : 1, 5-
aJpyra-zoloquinazolin-12-one 8. To 7 (5 mmol), aq
KOH (5%, 20 mL) was added and the reaction
mixture was refluxed for 10 h. The solid obtained
was recrystallized to give 8 (Table I).
Preparation of Schif's base 9. A mixture of 2
(10 mmol) and compound 1 (10 mmol) in gl acetic
acid (50 mL) was heated under reflux for 2 h, cooled
and poured onto ice. The resulting solid was
crystallized to give 9 (Table I).
Addition of sodium methoxide to 9: Formation
of 10. A suspention of 9 (0.5 g) in sodium
methoxide (0.5 g Na in 50 mL abs ethanol) was
refluxed for 12 h, cooled and poured onto ice-HCI.
the solid obtained was recrystallized to give the
adduct 10 (Table I).
Cycloaddition of 9 with thioglycolic acid:
Formation of thiazolidinone 11. A mixture of 9
(10 m.mol) and mercaptoacetic acid (50 m. mol) in
dioxan (100 mL) was refluxed for 8 h. The excess
solvent was removed and the resulting solid mass
was crystallized to give 11 (Table I).
Preparation of chalcones 12a and 12b. Equi-
molar mixture of 2 (10 mmol), the appropriate
acetophenones namely, 4-hydroxyacetophenone, p-
nitroacetophenone (10 mmol each) and acetic acid
(3.3 mL), piperidine (0.5 mL) in benzene (100 mL)
was refluxed for 24 h. The solid obtained was
filtered off and recrystallized from the proper
solvent to give 12a,b (TableI).
Synthesis of heterotricyclic system 13. A
mixture of 12b (0.5 g), ethanol (50 mL), and
piperidine (0.5 mL) was refluxed for 10 h. The solid
obtained was filtered off and recrystallized to give
13 (Table I).
Synthesis of isoxazole derivatives 14a,b. A
mixture of 12a,b (10 mmol) and hydroxylamine
hydrochloride (10 mmol in H20 5 mL), in pyridine
(50 mL) was refluxed for 6 h, cooled, -and poured
onto ice-HCl. The solid obtained was filtered off
and recrystallized to give 14 (Table I).
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